Regulatory15 May 2026, 08:32 pm
Alembic Pharma's API-III Facility Cleared by Brazilian ANVISA
AI Summary
Alembic Pharmaceuticals Ltd. announces successful completion of the Brazilian Health Regulatory Agency (ANVISA) GMP inspection at its API-III Facility in Karakhadi. The inspection, conducted from May 11, 2026, to May 15, 2026, resulted in clearance for multiple APIs without any observations, indicating adherence to GMP standards.
Key Highlights
- Alembic Pharma's API-III facility passes ANVISA GMP inspection.
- Inspection conducted from May 11 to May 15, 2026.
- Multiple APIs cleared without any observations.
- Facility located at Karakhadi.
Price Impact
More from APLLTD